Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of Clinical Pharmacology
|
March 26, 2009
Kerfuffle!
Thaddeus H Grasela, Elizabeth Ludwig, Jill Fiedler-Kelly
Science (New York, N.Y.)
|
October 20, 2022
Regulatory insight from low-income countries
Jackson K Mukonzo, David A Price, Thaddeus H Grasela
Clinical and Translational Science
|
April 9, 2021
COVID-19 vaccines and treatments: When speed is necessary and not enough
Thaddeus H Grasela, David A Price, John A Wagner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 5, 2005
The pharmacokinetic and pharmacodynamic profile of tigecycline
Alison K Meagher, Paul G Ambrose, Thaddeus H Grasela, et al.
Journal of Clinical Pharmacology
|
June 25, 2009
Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients
Sadahiro Abe, Koji Chiba, Brenda Cirincione, et al.
Diagnostic Microbiology and Infectious Disease
|
August 18, 2005
Pharmacokinetic/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent
Alison K Meagher, Paul G Ambrose, Thaddeus H Grasela, et al.
Journal of Pharmaceutical Sciences
|
September 25, 2025
Physiologically based pharmacokinetic modeling of hydroxyurea: Implications for dose adjustment in patients with renal insufficiency
Henry Enzama, Sandra Cvijic, Joshua Kiptoo, et al.
The Journal of Antimicrobial Chemotherapy
|
August 15, 2003
Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction
Paul G Ambrose, Sujata M Bhavnani, Brenda B Cirincione, et al.
Clinical and Translational Science
|
April 27, 2026
Advancing Pharmacoequity in Low- and Middle-Income Countries via Model Informed Drug Development
Henry Enzama, Francis Williams Ojara, Ian S Haworth, et al.
Surgical Infections
|
February 3, 2005
The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection
Philip S Barie, Ori D Rotstein, E Patchen Dellinger, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of Clinical Pharmacology
|
March 26, 2009
Kerfuffle!
Thaddeus H Grasela, Elizabeth Ludwig, Jill Fiedler-Kelly
Science (New York, N.Y.)
|
October 20, 2022
Regulatory insight from low-income countries
Jackson K Mukonzo, David A Price, Thaddeus H Grasela
Clinical and Translational Science
|
April 9, 2021
COVID-19 vaccines and treatments: When speed is necessary and not enough
Thaddeus H Grasela, David A Price, John A Wagner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 5, 2005
The pharmacokinetic and pharmacodynamic profile of tigecycline
Alison K Meagher, Paul G Ambrose, Thaddeus H Grasela, et al.
Journal of Clinical Pharmacology
|
June 25, 2009
Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients
Sadahiro Abe, Koji Chiba, Brenda Cirincione, et al.
Diagnostic Microbiology and Infectious Disease
|
August 18, 2005
Pharmacokinetic/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent
Alison K Meagher, Paul G Ambrose, Thaddeus H Grasela, et al.
Journal of Pharmaceutical Sciences
|
September 25, 2025
Physiologically based pharmacokinetic modeling of hydroxyurea: Implications for dose adjustment in patients with renal insufficiency
Henry Enzama, Sandra Cvijic, Joshua Kiptoo, et al.
The Journal of Antimicrobial Chemotherapy
|
August 15, 2003
Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction
Paul G Ambrose, Sujata M Bhavnani, Brenda B Cirincione, et al.
Clinical and Translational Science
|
April 27, 2026
Advancing Pharmacoequity in Low- and Middle-Income Countries via Model Informed Drug Development
Henry Enzama, Francis Williams Ojara, Ian S Haworth, et al.
Surgical Infections
|
February 3, 2005
The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection
Philip S Barie, Ori D Rotstein, E Patchen Dellinger, et al.
Page
of 2